Back to search
FDAFDA · Food and drugs·Recall number D-0283-2024

Rifampin Capsules USP 150mg, 30-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States, Manufactured Lupin Limited, Aurangabad 431 210 INDIA, NDC 68180-658-06

Published February 7, 2024 · Recall initiated: January 5, 2024

Summary

FDA records drug Class II recall D-0283-2024, published February 7, 2024 and initiated January 5, 2024. Recalling firm: Lupin Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 15,576 Bottles; Lot: A200816 exp 1/2024 A201248 exp 3/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug and Failed Impurities/Degradation Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if RIFAMPIN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
RIFAMPIN
Manufacturer
Lupin Pharmaceuticals Inc.
Distributor
Product was distributed to 32 Wholesale/distributor accounts who further distributed the product to 156 distribution sites.
Lot
A200816 exp 1/2024 A201248 exp 3/2024
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Rifampin Capsules USP 150mg, 30-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States, Manufactured Lupin Limited, Aurangabad 431 210 INDIA, NDC 68180-658-06 recalled?

Yes. FDA published recall D-0283-2024 on February 7, 2024. Reported hazard: Subpotent Drug and Failed Impurities/Degradation Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: RIFAMPIN.